Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries

Simple item page
dc.contributor.authorPetersen, Zainoen_ZA
dc.contributor.authorMyers, Bronwynen_ZA
dc.contributor.authorvan Hout, Marie-Claireen_ZA
dc.contributor.authorPluddemann, Andreasen_ZA
dc.contributor.authorParry, Charlesen_ZA
dc.date.accessioned2015-10-30T09:35:43Z
dc.date.available2015-10-30T09:35:43Z
dc.date.issued2013en_ZA
dc.description.abstractBACKGROUND:About a third of the global HIV infections outside sub-Saharan Africa are related to injecting drug use (IDU), and this accounts for a growing proportion of persons living with HIV. This paper is a response to the need to monitor the state of the HIV epidemic as it relates to IDU and the availability of HIV treatment and harm reduction services in 21 high epidemic countries. METHODS: A data collection form was designed to cover questions on rates of IDU, prevalence and incidence of HIV and information on HIV treatment and harm reduction services available to people who inject drugs (PWID). National and regional data on HIV infection, IDU in the form of reports and journal articles were sought from key informants in conjunction with a systematic search of the literature. RESULTS: Completed data collection forms were received for 11 countries. Additional country-specific information was sourced via the literature search. The overall proportion of HIV positive PWID in the selected countries ranged from 3% in Kazakhstan to 58% in Vietnam. While IDU is relatively rare in sub-Saharan Africa, it is the main driver of HIV in Mauritius and Kenya, with roughly 47% and 36% of PWID respectively being HIV positive. All countries had antiretroviral treatment (ART) available to PWID, but data on service coverage were mainly missing. By the end of 2010, uptake of needle and syringe programmes (NSP) in Bangladesh, India and Slovakia reached the internationally recommended target of 200 syringes per person, while uptake in Kazakhstan, Vietnam and Tajikistan reached between 100-200 syringes per person. The proportion of PWID receiving opioid substitution therapy (OST) ranged from 0.1% in Kazakhstan to 32.8% in Mauritius, with coverage of less than 3% for most countries. CONCLUSIONS: In order to be able to monitor the impact of HIV treatment and harm reduction services for PWID on the epidemic, epidemiological data on IDU and harm reduction service provision to PWID needs to be regularly collected using standardised indicators.en_ZA
dc.identifier.apacitationPetersen, Z., Myers, B., van Hout, M., Pluddemann, A., & Parry, C. (2013). Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries. <i>Harm Reduction Journal</i>, http://hdl.handle.net/11427/14533en_ZA
dc.identifier.chicagocitationPetersen, Zaino, Bronwyn Myers, Marie-Claire van Hout, Andreas Pluddemann, and Charles Parry "Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries." <i>Harm Reduction Journal</i> (2013) http://hdl.handle.net/11427/14533en_ZA
dc.identifier.citationPetersen, Z., Myers, B., Van Hout, M. C., Plüddemann, A., & Parry, C. (2013). Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries. Harm Reduct J, 10(13).en_ZA
dc.identifier.ris TY - Journal Article AU - Petersen, Zaino AU - Myers, Bronwyn AU - van Hout, Marie-Claire AU - Pluddemann, Andreas AU - Parry, Charles AB - BACKGROUND:About a third of the global HIV infections outside sub-Saharan Africa are related to injecting drug use (IDU), and this accounts for a growing proportion of persons living with HIV. This paper is a response to the need to monitor the state of the HIV epidemic as it relates to IDU and the availability of HIV treatment and harm reduction services in 21 high epidemic countries. METHODS: A data collection form was designed to cover questions on rates of IDU, prevalence and incidence of HIV and information on HIV treatment and harm reduction services available to people who inject drugs (PWID). National and regional data on HIV infection, IDU in the form of reports and journal articles were sought from key informants in conjunction with a systematic search of the literature. RESULTS: Completed data collection forms were received for 11 countries. Additional country-specific information was sourced via the literature search. The overall proportion of HIV positive PWID in the selected countries ranged from 3% in Kazakhstan to 58% in Vietnam. While IDU is relatively rare in sub-Saharan Africa, it is the main driver of HIV in Mauritius and Kenya, with roughly 47% and 36% of PWID respectively being HIV positive. All countries had antiretroviral treatment (ART) available to PWID, but data on service coverage were mainly missing. By the end of 2010, uptake of needle and syringe programmes (NSP) in Bangladesh, India and Slovakia reached the internationally recommended target of 200 syringes per person, while uptake in Kazakhstan, Vietnam and Tajikistan reached between 100-200 syringes per person. The proportion of PWID receiving opioid substitution therapy (OST) ranged from 0.1% in Kazakhstan to 32.8% in Mauritius, with coverage of less than 3% for most countries. CONCLUSIONS: In order to be able to monitor the impact of HIV treatment and harm reduction services for PWID on the epidemic, epidemiological data on IDU and harm reduction service provision to PWID needs to be regularly collected using standardised indicators. DA - 2013 DB - OpenUCT DO - 10.1186/1477-7517-10-13 DP - University of Cape Town J1 - Harm Reduction Journal LK - https://open.uct.ac.za PB - University of Cape Town PY - 2013 T1 - Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries TI - Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries UR - http://hdl.handle.net/11427/14533 ER - en_ZA
dc.identifier.urihttp://hdl.handle.net/11427/14533
dc.identifier.urihttp://dx.doi.org/10.1186/1477-7517-10-13
dc.identifier.vancouvercitationPetersen Z, Myers B, van Hout M, Pluddemann A, Parry C. Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries. Harm Reduction Journal. 2013; http://hdl.handle.net/11427/14533.en_ZA
dc.language.isoengen_ZA
dc.publisherBioMed Central Ltden_ZA
dc.publisher.departmentDepartment of Psychiatry and Mental Healthen_ZA
dc.publisher.facultyFaculty of Health Sciencesen_ZA
dc.publisher.institutionUniversity of Cape Town
dc.rightsThis is an open access article distributed under the terms of the Creative Commons Attribution Licenseen_ZA
dc.rights.holder2013 Petersen et al.; licensee BioMed Central Ltden_ZA
dc.rights.urihttp://creativecommons.org/licenses/by/2.0en_ZA
dc.sourceHarm Reduction Journalen_ZA
dc.source.urihttp://www.harmreductionjournal.com/en_ZA
dc.subject.otherAntiretroviral treatmenten_ZA
dc.subject.otherHIV/AIDS treatment programmesen_ZA
dc.subject.otherDrug Addictionen_ZA
dc.subject.otherAmphetamine Type Stimulantsen_ZA
dc.titleAvailability of HIV prevention and treatment services for people who inject drugs: findings from 21 countriesen_ZA
dc.typeJournal Articleen_ZA
uct.type.filetypeText
uct.type.filetypeImage
uct.type.publicationResearchen_ZA
uct.type.resourceArticleen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Petersen_Availability_of_HIV_prevention_drugs_2013.pdf
Size:
176.36 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Journal Articles